Cargando…

Prevalence and Evolution of Susceptibility‐Weighted Imaging Lesions in Patients With Artificial Heart Valves

BACKGROUND: In patients with mechanical heart valves, cerebral susceptibility‐weighted imaging (SWI) lesions on magnetic resonance imaging, postulated to be caused by degenerative metallic abrasion, are frequently referred to as valve abrasion. It remains unclear whether valve implantation not requi...

Descripción completa

Detalles Bibliográficos
Autores principales: Breiding, Philipe S., Duerrenmatt, Jana T., Meinel, Felix G., Carrel, Thierry, Schönhoff, Florian, Zibold, Felix, Kaesmacher, Johannes, Gralla, Jan, Pilgrim, Thomas, Jung, Simon, Fischer, Urs, Arnold, Marcel, Meinel, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761656/
https://www.ncbi.nlm.nih.gov/pubmed/31379252
http://dx.doi.org/10.1161/JAHA.119.012814
_version_ 1783454067986530304
author Breiding, Philipe S.
Duerrenmatt, Jana T.
Meinel, Felix G.
Carrel, Thierry
Schönhoff, Florian
Zibold, Felix
Kaesmacher, Johannes
Gralla, Jan
Pilgrim, Thomas
Jung, Simon
Fischer, Urs
Arnold, Marcel
Meinel, Thomas R.
author_facet Breiding, Philipe S.
Duerrenmatt, Jana T.
Meinel, Felix G.
Carrel, Thierry
Schönhoff, Florian
Zibold, Felix
Kaesmacher, Johannes
Gralla, Jan
Pilgrim, Thomas
Jung, Simon
Fischer, Urs
Arnold, Marcel
Meinel, Thomas R.
author_sort Breiding, Philipe S.
collection PubMed
description BACKGROUND: In patients with mechanical heart valves, cerebral susceptibility‐weighted imaging (SWI) lesions on magnetic resonance imaging, postulated to be caused by degenerative metallic abrasion, are frequently referred to as valve abrasion. It remains unclear whether valve implantation not requiring cardiopulmonary bypass or biological heart valves also shows those lesions. METHODS AND RESULTS: Two blinded readers rated SWI lesions and cerebral amyloid angiopathy probability according to established criteria on brain magnetic resonance imaging pre‐ and postinterventionally. We assessed the association between valve type/cardiopulmonary bypass use and SWI lesion count on the first postinterventional scan using multivariable logistic regression. On postinterventional magnetic resonance imaging, 57/58 (98%) patients with mechanical heart valves had at least 1 and 46/58 (79%) 3 or more SWI lesions, while 92/97 (95%) patients with biological heart valves had at least 1 and 72/97 (74%) 3 or more SWI lesions. On multivariate analysis, duration of cardiopulmonary bypass during implantation significantly increased the odds of having SWI lesions on the first postinterventional magnetic resonance imaging (β per 10 minutes 0.498; 95% CI, 0.116–0.880; P=0.011), whereas valve type showed no significant association (P=0.338). Thirty‐seven of 155 (23.9%) patients fulfilled the criteria of possible/probable cerebral amyloid angiopathy. CONCLUSIONS: SWI lesions in patients with artificial heart valves evolve around the time point of valve implantation and the majority of patients had multiple lesions. The missing association with the valve type weakens the hypothesis of degenerative metallic abrasion and highlights cardiopulmonary bypass as the main risk factor for SWI occurrence. SWI lesions associated with cardiac procedures can mimic cerebral amyloid angiopathy. Further research needs to clarify whether those lesions are associated with intracranial hemorrhage after intravenous thrombolysis or anticoagulation.
format Online
Article
Text
id pubmed-6761656
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67616562019-09-30 Prevalence and Evolution of Susceptibility‐Weighted Imaging Lesions in Patients With Artificial Heart Valves Breiding, Philipe S. Duerrenmatt, Jana T. Meinel, Felix G. Carrel, Thierry Schönhoff, Florian Zibold, Felix Kaesmacher, Johannes Gralla, Jan Pilgrim, Thomas Jung, Simon Fischer, Urs Arnold, Marcel Meinel, Thomas R. J Am Heart Assoc Original Research BACKGROUND: In patients with mechanical heart valves, cerebral susceptibility‐weighted imaging (SWI) lesions on magnetic resonance imaging, postulated to be caused by degenerative metallic abrasion, are frequently referred to as valve abrasion. It remains unclear whether valve implantation not requiring cardiopulmonary bypass or biological heart valves also shows those lesions. METHODS AND RESULTS: Two blinded readers rated SWI lesions and cerebral amyloid angiopathy probability according to established criteria on brain magnetic resonance imaging pre‐ and postinterventionally. We assessed the association between valve type/cardiopulmonary bypass use and SWI lesion count on the first postinterventional scan using multivariable logistic regression. On postinterventional magnetic resonance imaging, 57/58 (98%) patients with mechanical heart valves had at least 1 and 46/58 (79%) 3 or more SWI lesions, while 92/97 (95%) patients with biological heart valves had at least 1 and 72/97 (74%) 3 or more SWI lesions. On multivariate analysis, duration of cardiopulmonary bypass during implantation significantly increased the odds of having SWI lesions on the first postinterventional magnetic resonance imaging (β per 10 minutes 0.498; 95% CI, 0.116–0.880; P=0.011), whereas valve type showed no significant association (P=0.338). Thirty‐seven of 155 (23.9%) patients fulfilled the criteria of possible/probable cerebral amyloid angiopathy. CONCLUSIONS: SWI lesions in patients with artificial heart valves evolve around the time point of valve implantation and the majority of patients had multiple lesions. The missing association with the valve type weakens the hypothesis of degenerative metallic abrasion and highlights cardiopulmonary bypass as the main risk factor for SWI occurrence. SWI lesions associated with cardiac procedures can mimic cerebral amyloid angiopathy. Further research needs to clarify whether those lesions are associated with intracranial hemorrhage after intravenous thrombolysis or anticoagulation. John Wiley and Sons Inc. 2019-08-05 /pmc/articles/PMC6761656/ /pubmed/31379252 http://dx.doi.org/10.1161/JAHA.119.012814 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Breiding, Philipe S.
Duerrenmatt, Jana T.
Meinel, Felix G.
Carrel, Thierry
Schönhoff, Florian
Zibold, Felix
Kaesmacher, Johannes
Gralla, Jan
Pilgrim, Thomas
Jung, Simon
Fischer, Urs
Arnold, Marcel
Meinel, Thomas R.
Prevalence and Evolution of Susceptibility‐Weighted Imaging Lesions in Patients With Artificial Heart Valves
title Prevalence and Evolution of Susceptibility‐Weighted Imaging Lesions in Patients With Artificial Heart Valves
title_full Prevalence and Evolution of Susceptibility‐Weighted Imaging Lesions in Patients With Artificial Heart Valves
title_fullStr Prevalence and Evolution of Susceptibility‐Weighted Imaging Lesions in Patients With Artificial Heart Valves
title_full_unstemmed Prevalence and Evolution of Susceptibility‐Weighted Imaging Lesions in Patients With Artificial Heart Valves
title_short Prevalence and Evolution of Susceptibility‐Weighted Imaging Lesions in Patients With Artificial Heart Valves
title_sort prevalence and evolution of susceptibility‐weighted imaging lesions in patients with artificial heart valves
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761656/
https://www.ncbi.nlm.nih.gov/pubmed/31379252
http://dx.doi.org/10.1161/JAHA.119.012814
work_keys_str_mv AT breidingphilipes prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT duerrenmattjanat prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT meinelfelixg prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT carrelthierry prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT schonhoffflorian prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT ziboldfelix prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT kaesmacherjohannes prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT grallajan prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT pilgrimthomas prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT jungsimon prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT fischerurs prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT arnoldmarcel prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves
AT meinelthomasr prevalenceandevolutionofsusceptibilityweightedimaginglesionsinpatientswithartificialheartvalves